Neural Therapeutics Company Description

Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances.

It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments.

Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021.

The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Neural Therapeutics Inc.

Country	Canada
Founded	2020
Industry	Biological Products, Except Diagnostic Substances
CEO	Ian Campbell

Contact Details

Address: 77 King Street West Toronto, Ontario M5K 1H1 Canada
Website	neuraltherapeutics.ca

Stock Details

Ticker Symbol	NURL
Exchange	Canadian Securities Exchange
Fiscal Year	August - July
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Ian Campbell	Chief Executive Officer
Omar Gonzalez	Chief Financial Officer